220
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T40997 |
GLP-1R modulator C16
GLP-1R modulator C16 |
Glucagon Receptor | GPCR/G Protein |
GLP-1R modulator C16 是一种变构调节剂,显著增加了 GLP-4 的结合亲和力。 | |||
T11409 |
GLP-26
|
HBV | Microbiology/Virology |
GLP-26 是一种HBV 衣壳组装调节剂,抑制 Hep AD38 系统中的 HBV DNA 复制,IC50值为3 nM。 在 1 μM 时,使 cccDNA 降低> 90%。它破坏前基因组 RNA 的衣壳化,导致核衣壳解体,并减少 cccDNA 库。 | |||
T40279 |
GLP-1R modulator L7-028
GLP-1R modulator L7-028 |
cAMP; Glucagon Receptor | GPCR/G Protein |
GLP-1R modulator L7-028 是一种变构调节剂,增强了对 GLP-1 的亲和力和 cAMP 信号转导。 | |||
T37890L |
GLP-1(28-36)amide acetate
GLP-1(28-36)amide acetate(1225021-13-5 Free base) |
Antioxidant; Glucagon Receptor | GPCR/G Protein; oxidation-reduction |
GLP-1(28-36)amide acetate 抑制线粒体通透性转变,具有抗氧化、抗糖尿病和心脏保护活性。 | |||
T9579L |
GLP-1 receptor agonist 9 citrate
GLP-1 receptor agonist 9 citrate (2401892-71-3 Free base) |
Glucagon Receptor | GPCR/G Protein |
GLP-1 receptor agonist 9 citrate 是 GLP-1 的激动剂。 | |||
T37891L |
GLP-1(32-36)amide acetate
GLP-1(32-36)amide 醋酸盐,GLP-1(32-36)amide acetate(1417302-71-6 Free base) |
Others | Others |
GLP-1(32-36)amide acetate 是一种五肽,衍生自糖调节激素 GLP-1 的 C 末端。GLP-1(32-36)amide acetate 可抑制糖尿病小鼠的体重增加并调节全身葡萄糖代谢。 | |||
TP1376 |
GLP-1(7-37) acetate(106612-94-6 free base)
GLP-1(7-37) acetate |
Others; Glucagon Receptor | GPCR/G Protein; Others |
GLP-1(7-37) acetate 是肠道胰岛素激素,能够促进葡萄糖诱导的胰岛素分泌。 | |||
TP2252 |
GLP-1 (9-36) amide
|
Glucagon Receptor | GPCR/G Protein |
GLP-1(9-36)amide 是胰高血糖素样肽-1 (7-36) amide 的主要代谢产物,对人胰腺 GLP-1受体具有拮抗作用。 | |||
T15387 | GLP-1R Antagonist 1 | Glucagon Receptor | GPCR/G Protein |
GLP-1R Antagonist 1 (compound 5d) 是口服有效的、能透过中枢神经系统的,胰高血糖素样肽 1 受体 (GLP-1R) 的非竞争性抑制,其 IC50 值为 650 nM。 | |||
T36579 |
GLP-1R Agonist DMB
|
Glucagon Receptor | GPCR/G Protein |
GLP-1R Agonist DMB 是胰高血糖素样肽1受体的激动剂(GLP-1R;重组人受体的 KB=26.3nM)。 | |||
TP2253 |
GLP-2(rat)
GLP-2 (rat) |
Others | Others |
intestinal epithelium-specific growth factor | |||
T11408 |
Orforglipron
LY3502970,GLP-1 receptor agonist 1 |
Glucagon Receptor | GPCR/G Protein |
Orforglipron (LY3502970; GLP-1 receptor agonist 1) 是一种可口服的胰高血糖素样肽 (GLP-1) 受体激动剂,可用于研究成人肥胖和1型糖尿病。 | |||
TP1141 |
GLP-1(7-36), amide acetate
GLP-1(7-36) Acetate,Human GLP-1-(7-36)-amide Acetate |
||
GLP-1(7-36) Acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells. | |||
TP1157 |
GLP-2(1-33)(human)
GLP-2 (human),Glucagon-like peptide 2 (human) |
||
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium. | |||
T3984 |
GLP-1(7-36), amide
MKC 253,胰高血糖素样肽-1,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide |
Glucagon Receptor | GPCR/G Protein |
GLP-1(7-36), amide (MKC 253) 是一种生理性肠降血糖素,能够刺激胰岛素分泌。 | |||
T63909 |
GLP-1R agonist 3
|
Glucagon Receptor | GPCR/G Protein |
GLP-1R agonist 3 是增稠的咪唑衍生物化合物,是 GLP-1R 的有效激动剂。其中胰高血糖素样肽-1 (GLP-1) 是一种肠道降血糖激素,由下消化道 L 细胞分泌。GLP-1R agonist 3 对糖尿病表现出研究潜力。 | |||
T61483 |
GLP-1R modulator C5
|
Glucagon Receptor | GPCR/G Protein |
GLP-1R modulator C5 是一种小分子 GLP-1R 正变构调节剂,通过跨膜位点增强GLP-1与GLP-1R的结合,可用于研究 II 型糖尿病。。 | |||
T9701 |
GLP-2(3-33)
|
||
T37891 |
GLP-1(32-36)amide
|
||
GLP-1(32-36)amide is a pentapeptide compound derived from the C terminus of the glucoregulatory hormone GLP-1. This compound has shown potential in inhibiting weight gain and regulating glucose metabolism in diabetic mice[1][2]. | |||
TP1306 |
GLP-1(7-37)
|
||
GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells. | |||
T36380 |
GLP-1 (1-36) amide (human, rat) (trifluoroacetate salt)
|
||
GLP-1 amide is a peptide hormone cleaved from proglucagon in the pancreas.1,2 Mice lacking the glucagon receptor (Gcgr-/-) have approximately nine-fold higher levels of total GLP-1 amide, including GLP-1 (1-36) amide and truncated GLP-1 (7-36) amide , in pancreatic tissue compared to wild-type mice.2References1. Schjoldager, B.T., Mortensen, P.E., Christiansen, J., et al. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans... | |||
T37890 |
GLP-1(28-36)amide
|
||
GLP-1(28-36)amide, a C-terminal nonapeptide derived from the cleavage of GLP-1 by neutral endopeptidase (NEP), is a significant product. It functions as an antioxidant and primarily targets the mitochondrion, where it effectively inhibits mitochondrial permeability transition (MPT). This compound exhibits anti-diabetic properties and demonstrates cardioprotection effects[1]. | |||
T11404 | GLP-1 receptor agonist 3 | Others | Others |
GLP-1 receptor agonist 3 is a GLP-1 receptor agonist,Example 4A-1, has EC50s of 1.1 nM and 13 nM in Clone H6 and Clone C6 cell lines assay, respectively. | |||
TP1316 |
GLP-1 moiety from Dulaglutide
|
||
GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist. | |||
T9579 |
GLP-1 receptor agonist 9
|
Glucagon Receptor | GPCR/G Protein |
1H-Benzimidazole-6-carboxylic acid 是GLP-1 receptor 激动剂。 | |||
T37892 |
GLP-1(7-36), amide TFA
|
||
GLP-1(7-36), amide TFA is a prominent intestinal hormone known to stimulate glucose-induced insulin secretion from β cells[1]. | |||
T11407 |
GLP-1 receptor agonist 2
|
Others | Others |
GLP-1 receptor agonist 2 is a glucagon-like peptide-1 receptor (GLP-1R) agonist. | |||
T78571 |
Albiglutide fragment TFA
GLP-1-Gly8 TFA,GLP-1 (7-36) analog TFA |
||
Albiglutide fragment (GLP-1 (7-36) analog) TFA为Albiglutide活性片段,代表胰高血糖素样肽-1(GLP-1)模拟物,属长效GLP-1受体激动剂。由GLP-1二聚体抗DPP-4特性与人白蛋白基因融合而成,本化合物在降低糖化血红蛋白(A1C)方面表现显著,主要应用于2型糖尿病(T2D)的相关研究。 | |||
T11405 |
GLP-1 receptor agonist 4
|
Others | Others |
GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist , has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes. | |||
TP1487 |
Glucagon-Like Peptide (GLP) II, human
|
||
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a po | |||
T9701L | GLP-2(3-33) aceate (275801-62-2 Free base) | ||
T72611 | GLP-1R agonist 17 | ||
GLP-1R agonist 17,一种表现出极佳激动作用于GLP-1受体的GLP-1受体激动剂,适用于心血管代谢疾病研究。 | |||
T75823 |
GLP-2(rat) TFA
|
||
GLP-2(rat) TFA为肠道生长因子,能刺激细胞增殖、抑制凋亡,且在大肠小肠切除术(MSBR)后,可提升残留小肠粘膜的品质与功能。 | |||
T64007 | GLP-1R agonist 10 | ||
GLP-1R agonist 10 是一种 GLP-1 激动剂 (EC50: 0.051 nM)。 | |||
T63999 | GLP-1R agonist 8 | ||
GLP-1R agonist 8 是 GLP-1R 的有效激动剂 (EC50<2 nM)。 | |||
T74609 | GLP-1R agonist 15 | ||
GLP-1R agonist 15 (Compound 101) 是一种GLP-1受体激动剂。 | |||
T72686 |
GLP-1R agonist 9
|
||
GLP-1R agonist 9 是一种 GLP-1R 激动剂,对 CHO GLP-1R Clone H6 和 CHO GLP-1R Clone C6 的 EC50分别为 1.1 nM 和 11 nM。 | |||
T64180 |
GLP-1R agonist 1
|
||
GLP-1R agonist 1 是一种增稠的咪唑衍生物化合物,也是一种 GLP-1R 的有效激动剂。其中胰高血糖素样肽-1 (GLP-1) 是一种肠道降血糖激素,分泌自下消化道 L 细胞。GLP-1R agonist 1 具有研究糖尿病的潜力。 | |||
T74608 |
GLP-1R agonist 14
|
||
GLP-1R agonist 14 (Compound 14) 是一种GLP-1受体激动剂,对 h-GLP-1 的EC50为 0-20 nM。 | |||
T74610 |
GLP-1R agonist 16
|
||
GLP-1R agonist 16 (Compound 115a) 是一种GLP-1受体激动剂,EC50为 0.15 nM。 | |||
T64191 |
GLP-1R agonist 12
|
||
GLP-1R agonist 12 (Compound 123) 是一种 GLP-1R 激动剂,能够用于研究糖尿病。 | |||
T74323 |
GLP-1R agonist 4
|
||
GLP-1R agonist 4 是一种有效的 GLP-1R 激动剂。胰高血糖素样肽-1 (GLP-1) 是一种由下消化道 L 细胞分泌的肠道降血糖激素。GLP-1R agonist 4 具有糖尿病研究潜力。 | |||
T79348 |
GLP-1 receptor agonist 13
|
||
GLP-1 受体激动剂 13 (化合物 (S)-9) 是一种具有EC50值为76 nM的胰高血糖素类似物,其作用机制是激活GLP-1受体。 | |||
T64195 | GLP-1 receptor agonist 7 | ||
GLP-1 receptor agonist 7 是一种有效的胰高血糖素样肽-1 (GLP-1) 激动剂。GLP-1 receptor agonist 7 对 GLP-1 相关疾病、障碍和病症 (包括糖尿病) 表现出研究潜力。 | |||
T82307 |
Glp-His-Pro-Gly-NH2
pGlu-His-Pro-Gly-NH2 |
||
pGlu-His-Pro-Gly-NH2(Glp-His-Pro-Gly-NH2)为含四氨基酸肽类化合物,可激发促性腺激素、黄体生成素(LH)与促卵泡激素(FSH)释放。 | |||
T74132 |
GLP-1 receptor agonist 8
|
||
GLP-1 receptoragonist 8 是一种有效的GLP-1R 激动剂。GLP-1 receptoragonist 8 具有研究糖尿病、肥胖和非酒精性脂肪肝 (NAFLD) 的潜力。 | |||
T82308 |
GLP-2 (1-34) (human)
|
||
GLP-2 (1-34) (human) 是一种肠道多肽,其在进食后数分钟内释放,并可用于研究骨重塑过程。 | |||
T75822 |
GLP-1(9-36)amide TFA
|
||
GLP-1(9-36)amide TFA, 作为胰高血糖素样肽-1 (7-36)amide的主要代谢产物,是人胰腺GLP-1受体的拮抗剂。 | |||
T76191 |
GLP-1(28-36)amide TFA
|
||
GLP-1(28-36)amide TFA,为GLP-1 C-端九肽段,主要通过中性内肽酶(NEP)裂解GLP-1生成。该化合物作为一种抗氧化剂,能靶向线粒体,抑制线粒体通透性转变(MPT),显示出抗糖尿病和心脏保护的功效。 | |||
TP2340 |
Hemoregulatory peptide 5b
hp 5B,Pglu-glu-asp-cys-lys-OH,Peedck,Glp-glu-asp-cys-lys-OH,SP1 Pentapeptide |
||
Hemoregulatory peptide 5b is a synthetic analog of granulocyte chalone which initially identified in extracts of rodent bone marrow and human leukocytes. Monomer inhibits both formations of GM-CFC colonies and cytotoxic drug-induced recruitment of murine |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3896 |
Shanzhiside methyl ester
三栀子甙甲酯,山芝皂苷甲酯 |
Glucagon Receptor | GPCR/G Protein |
Shanzhiside methyl ester 是一种小分子胰高血糖素样肽 1 受体激动剂,分离自轮状乳杆菌,能够诱导抗异常性痛觉耐受。 | |||
T19117 |
3-Deoxyglucosone
3-Deoxy-D-glucosone,2-keto-3-Deoxyglucose |
GPX; Glucagon Receptor | GPCR/G Protein; oxidation-reduction |
3-Deoxyglucosone(3-Deoxy-D-glucosone) 是美拉德反应和多元醇反应的中间体途径合成。3-Deoxyglucosone 与蛋白质氨基快速反应形成晚期糖基化末端蛋白 (AGEs)。3-Deoxyglucosone 可使谷胱甘肽过氧化物酶失活,可与低葡萄糖协同作用以增强 GLP-1 分泌,可以作为糖尿病生物学检测的标志物。 | |||
T37526 |
2-Oleoylglycerol
2-Oleoyl Glycerol,2-OG,2-Monoolein |
GPR | Endocrinology/Hormones; GPCR/G Protein |
2-Oleoylglycerol 是一种存在于棕榈仁、葵花籽和米糠中的脂质。2-Oleoylglycerol 可当作一种 GPR119 激动剂,具有神经保护作用,可诱导胰高血糖素样肽 1 (GLP-1) 分泌。2-Oleoylglycerol 可用于非酒精性脂肪性肝炎造模。 | |||
T40977 |
Cinnamtannin A2
肉桂鞣质A2 |
||
Cinnamtannin A2, a tetrameric procyanidin, enhances GLP-1 and insulin secretion in mice while also upregulating the expression of corticotrophin releasing hormone. Additionally, Cinnamtannin A2 exhibits antioxidant, anti-diabetic, and nephroprotective effects. |